SCHEMBL4348569

SCHEMBL4348569

CS(=O)(=O)c1ccc(-c2ccc3c(c2)COC(C2CCN(C(=O)c4ncc(F)cc4F)CC2)O3)cc1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 7/20 0.39
PIK3CA P42336 2/20 0.38
USP30 Q70CQ3 1/20 0.35
PDE2A O00408 1/20 0.34
PTGS2 P35354 1/20 0.33
RBP4 P02753 1/20 0.33
DPP4 P27487 1/20 0.33
DPP9 Q86TI2 1/20 0.33
SLC6A9 P48067 2/20 0.33
GPR55 Q9Y2T6 1/20 0.33
CYP11B2 P19099 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355702 0.83 PIK3CA (0.37) GPR119PIK3CAUSP30PTGS2CYP11B2
SCHEMBL4353588 0.82 PIK3CA (0.43) GPR119PIK3CAUSP30SLC6A9
SCHEMBL4535480 0.82 LMNA (0.42) GPR119PIK3CAUSP30CYP11B2
SCHEMBL4347925 0.82 USP30 (0.40) GPR119PIK3CAUSP30PTGS2DPP4
SCHEMBL4357301 0.81 PIK3CA (0.35) GPR119PIK3CAUSP30PTGS2
SCHEMBL4537918 0.81 PTPN2 (0.43) PIK3CACA12CA1CA2
SCHEMBL4356473 0.81 PTPN2 (0.43) PIK3CACA12CA1CA2
SCHEMBL4349922 0.81 PTPN2 (0.43) PIK3CACA12CA1CA2
SCHEMBL4356151 0.81 GAA (0.42) GPR119PIK3CARBP4
SCHEMBL4531447 0.80 PIK3CA (0.44) GPR119PIK3CAUSP30PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009150144-A1 NEW GPR119MODULATORS INOVACIA AB (SE) 2009-12-17 WO claimed
WO-2009150144-A1 NEW GPR119MODULATORS INOVACIA AB (SE) 2009-12-17 WO disclosed
WO-2009150144-A1 NEW GPR119MODULATORS INOVACIA AB (SE) 2009-12-17 WO disclosed